Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Dihydrexidine: Began Phase I testing of safety and efficacy in 10 patients, using several doses up to 10 mg/kg. Motor function will be measured with a commonly-

Interneuron Pharmaceuticals Inc. (IPIC),

Read the full 48 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE